Gain Therapeutics Plans To Initiate Phase 2 Rexaceract Trial In Q1 Next Year

Benzinga Newsdesk www.benzinga.com Neutral 92.6%

Neg 0% Neu 92.6% Pos 0%

https://www.sec.gov/ix?doc=/Archives/edgar/data/1819411/000110465926112624/tm2626750d1_8k.htm

Comments

No comments yet. Be the first!